Surveillance of viral pathogens in Australia: respiratory syncytial virus
DOI:
https://doi.org/10.33321/cdi.2003.27.9Abstract
Since the identification of respiratory syncytial virus (RSV) in the late 1950s, it has been recognised as a major cause of lower respiratory tract infection in young children.1 RSV is a member of the paramyxovirus family, an RNA virus related to other respiratory viruses such as influenza and parainfluenza.
Downloads
References
Hall CB, McCarthy CA. Respiratory syncytial virus. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's Principles and Practices of Infectious Diseases. 4th ed. New York: Churchill Livingstone, 1995:1501-1519.
Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-1928.
Goldmann DA. Epidemiology and prevention of pediatric viral respiratory infections in health-care institutions. Emerg Infect Dis 2001;7:249-253.
Hall CB, Douglas RG Jr. Modes of transmission of respiratory syncytial virus. J Pediatr 1981;99:100-103.
Henderson FW, Collier AM, Clyde WA Jr, Denny FW. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective longitudinal study in young children. N Engl J Med 1979;300:530-534.
Krilov LR. Respiratory virus infection. eMedicine (online) 2002. Available from: http://www.emedicine.com/PED/topic2706.htm. Accessed 31 October 2002.
Ison MG, Hayden FG. Viral infections in immunocompromised patients: what's new with respiratory viruses? Curr Opin Infect Dis 2002;15:355-367.
Dowell SF, Anderson LJ, Gary HE Jr, Erdman DD, Plouffe JF, File TM Jr, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis 1996;174:456-462.
Zambon MC, Stockon JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 2001;358:1410-1416.
Domachowske JB, Rosenberg HF. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev 1999;12:298-309.
Randolph AG, Wang EEL. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract (Cochrane review) (online). Available from: www.cochrane.org/cochrane/revabstr/ab000181.htm. Accessed 31 October 2002.
Brandenburg AH, Neijens HJ, Osterhaus AD. Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development. Vaccine 2001;19:2769-2782.
Martinello RA, Chen MD, Weibel C, Kahn JS. Correlation between respiratory syncytial virus genotype and severity of illness. J Infect Dis 2002;186:839-842.
Buckingham SC, Bush AJ, Devincenzo JP. Nasal quantity of respiratory syncytial virus correlates with disease severity in hospitalized infants. Pediatr Infect Dis J 2000;19:113-117.
Hall CB, Douglas RG Jr, Geiman JM. Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr 1976;89:11-15.
Wright PF, Gruber WC, Peters M, Reed G, Zhu Y, Robinson F, et al. Illness severity, viral shedding and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. J Infect Dis 2002;185:1011-1018.
Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with interleukin 8 gene region in UK families. Thorax 2000;55: 1023-1027.
McNamara PS, Smyth RL. The pathogenesis of respiratory syncytial virus disease in childhood. Br Med Bull 2002;61:13-28.
Polack FP, Teng MN, Collins PL, Prince GA, Exner M, Regele H, et al. A role for immune complexes in enhanced respiratory syncytial virus disease. J Exp Med 2002;196:859-865.
Message SD, Johnston SL. Viruses in asthma. Br Med Bull 2002;61:29-43.
Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-545.
Piedimonte G. Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae. Am J Respir Crit Care Med 2001;163:S18-S21.
The IMpact-RSV study group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-537.
Karron RA, Wright PF, Crowe JE Jr, Clements-Mann ML, Thompson J, Makhene M, et al. Evaluation of two live, cold-passaged, temperature sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J Infect Dis 1997;176:1428-1436.
Lewis FA, Rae ML, Lehmann NI, Ferris AA. A syncytial virus associated with epidemic disease of the lower respiratory tract in infants and young children. Med J Aust 1961;2:932-933.
Forbes JA, Bennett NM, Gray NJ. Epidemic bronchiolitis caused by a respiratory syncytial virus: clinical aspects. Med J Aust 1961;2:933-935.
Murphy B, Phelan PD, Jack I, Uren E. Seasonal pattern in childhood viral lower respiratory tract infections in Melbourne. Med J Aust 1980;1:22-24.
De Silva LM, Hanlon MG. Respiratory syncytial virus: a report of a 5-year study at a children's hospital. J Med Virol 1986;19:299-305.
De Silva LM. Respiratory syncytial virus in children's hospitals. Lancet 1991;338:1595-1596.
McIntosh ED, De Silva LM, Oates RK. Clinical severity of respiratory syncytial virus group A and B infection in Sydney, Australia. Pediatr Infect Dis 1993;12:815-819.
McLaws ML, Murphy C, Taylor P, Ferson M, Gold J, Donnellan R, et al. Rate of seasonal spread of respiratory syncytial virus in a pediatric hospital. Infect Control Hosp Epidemiol. 1997;18:778-780.
Lister S, McIntyre P, Menzies R. The epidemiology of respiratory syncytial virus infections in NSW children, 1992-1997. NSW Public Health Bulletin 2000;11:119-123.
Numa A. Outcome of respiratory syncytial virus infection and a cost-benefit analysis of prophylaxis. J Paediatr Child Health. 2000;36:422-427.
Read AW, Gibbins J, Stanley FJ. Hospital admissions for lower respiratory tract illness before the age of two years in Western Australia. Paediatr Perinat Epidemiol 1996;10:175-185.
Whitehall JS, Bolisetty S, Whitehall JP, Francis F, Norton R, Patole SK. High rate of indigenous bronchiolitis and palivuzumab. J of Paediat Child Health 2001;37:416-417.
Victorian Infectious Diseases Reference Laboratory. Surveillance briefs - influenza. Victorian Infectious Diseases Bulletin 2002;5:50-51.
Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2002;2:25-32.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2003 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
